AXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic Assays
11 avr. 2023 09h00 HE | AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Begins Manufacturing of Ocular Immunoglobulin (IgE), Lactoferrin Tests to Fulfill Orders From Commercialization Partner SAN DIEGO, CA, April 11, 2023 ...
BransWay logo.jpg
BrainsWay Debuts “#TheRealOCD” Campaign and Video on Obsessive-Compulsive Disorder (OCD)
13 oct. 2020 09h00 HE | BrainsWay
CRESSKILL, N.J., Oct. 13, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
BransWay logo.jpg
BrainsWay to Participate in Virtual Conferences Elevate by Psych Congress Virtual Experience and Online Obsessive-Compulsive Disorder (OCD) in July 2020
21 juil. 2020 09h00 HE | BrainsWay Ltd.
PATTERSON, N.J., July 21, 2020 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in the advanced noninvasive treatment of brain disorders,...
Logo.jpg
Endonovo Therapeutics Expands SofPulse® Sales to Plastic Surgery Centers
30 janv. 2020 07h00 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced sales of SofPulse® units to multiple Plastic Surgery...
Logo.jpg
Endonovo Therapeutics Announces First SofPulse® Sales to a Veterans Medical Center
27 janv. 2020 07h00 HE | Endonovo Therapeutics, Inc.
Los Angeles, CA, Jan. 27, 2020 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company") today announced initial sales of SofPulse® units into a VA hospital in...
sintx_grn_blk@4x-8.png
Amedica Receives Positive Nasdaq Listing Decision
01 déc. 2017 09h00 HE | Amedica Corporation
SALT LAKE CITY, Dec. 01, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative biomaterial company that develops and manufactures silicon nitride as a platform...
sintx_grn_blk@4x-8.png
Amedica Announces Adjournment of Special Meeting of Stockholders
03 oct. 2017 10h25 HE | Amedica Corporation
SALT LAKE CITY,, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Amedica Corporation (Nasdaq:AMDA), an innovative medical device company that develops and commercializes silicon nitride, announced that the...